# Vital Therapies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vital-therapies

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.vitaltherapies.com
- Total disclosed funding: $59M
- Latest round: Series D (Jun 13, 2011)
- Investors on record: 9

## About

Vital Therapies, Inc. is a biotechnology company focused on developing therapies for patients with liver failure. The company aims to provide innovative solutions through its proprietary technology.Founded in 2003, Vital Therapies, Inc. is based in San Diego, US, specializing in treatments for liver conditions. The firm completed its IPO in April 2014, raising USD 54.00 mn by selling 4.5 million shares at a price of USD 12. The CEO is Ec Hubbard.Vital Therapies, Inc. specializes in developing novel therapies aimed at addressing liver failure. The company's flagship product leverages its proprietary technology to provide a potential treatment option for patients with acute liver injury, enhancing the prospects of recovery through innovative therapeutic applications.In the most recent year reported, Vital Therapies, Inc. recorded an EBITDA of USD -41.30 mn, reflecting the company's ongoing research and development efforts in the biotechnology sector.Vital Therapies, Inc. seeks to advance its product pipeline, focusing on expanding its therapeutic offerings for liver diseases. The company plans to utilize the capital raised from its IPO in April 2014 to support clinical trials and research initiatives. There are no specific details on new market expansions or product launches provided at this time.

## Funding rounds

- Series D, Jun 13, 2011, $23M — Delphi Ventures, MedVenture Associates, Versant Ventures, Valley Ventures, Toucan Capital, Heights Capital Management
- Series C, Sep 12, 2007, $28M — Delphi Ventures, MedVenture Associates, Versant Ventures, Valley Ventures, HBM Partners, Toucan Capital, DFJ DragonFund China, Heights Capital Management
- Series B, Nov 1, 2005, $8M — MedVenture Associates, Paragon Venture Partners, Valley Ventures, Toucan Capital

## Investors

- MedVenture Associates (https://capitalatlas.ai/funds/medventure-associates) — Series B, Series C, Series D
- Paragon Venture Partners (https://capitalatlas.ai/funds/paragon-venture-partners) — Series B
- Valley Ventures (https://capitalatlas.ai/funds/valley-ventures) — Series B, Series C, Series D
- Toucan Capital (https://capitalatlas.ai/funds/toucan-capital) — Series B, Series C, Series D
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series C, Series D
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series C, Series D
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C
- DFJ DragonFund China (https://capitalatlas.ai/funds/dfj-dragonfund-china) — Series C
- Heights Capital Management (https://capitalatlas.ai/funds/heights-capital-management) — Series C, Series D